Evaluation of Topical B12 for the Treatment of Childhood Atopic Dermatitis

Status unconfirmed · Not applicable

Conditions studied: Eczema

In brief

This study is being done to see in B12 applied to the skin will improve the symptoms of eczema in children compared to a placebo creme

Key facts

Study ID

NCT00465699

Run by

Spartanburg Regional Healthcare System

People needed

50

Starts

2007-04-01

Expected to finish

2007-04-01

Last updated by the study team

2007-04-25

Who can join

Age: 1 and older, up to 18. Sex: any. Healthy volunteers: accepted.

You may qualify if…

• children presenting to the Center for Family Medicine or Regional Pediatrics between the ages of 6 months and 18 years old with atopic dermatitis

You may not qualify if…

• unwillingness of parent to consent to study protocol, pregnancy or lactation, eczema with superinfection present, known history of allergy to Vitamin B12 or components of the base cream, topical treatment with corticosteroids in the 4 weeks prior to enrollment

Where it is running

• Center for Family Medicine — Spartanburg, South Carolina, United States (enrolling)

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.